Effects of fish oil supplementation on pre diabetes in patients with chronic hepatitis C.
Not Applicable
Recruiting
- Conditions
- Hepatitis C virus-infected patients, insulin resistanceB18.2
- Registration Number
- RBR-4njyw9
- Lead Sponsor
- niversidade Federal da Bahia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Adults (age > 18 years) diagnosed with chronic hepatitis C (genotype I); either non responders or naive patients; alcohol consumption < 40g/dia; HOMA index > 2.5; Signature of term consent
Exclusion Criteria
Diabetics or those using drugs to alleviate insulin resistance, co-infected (HIV or HBV), hepatitis with autoimmune or use of antiviral treatment (interferon and ribavirin), decompensated liver disease or patients with hepatocellular carcinoma; With other neoplasias; Patients with chronic renal failure or decompensated heart failure.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of insulin resistance, according Homa, in patients with chronic hepatitis C after supplementation with omega 3 fatty acids
- Secondary Outcome Measures
Name Time Method Reduction of inflammatory cytokines (IL-1,IL-6, TNF) in patients with chronic hepatitis C after supplementation with omega 3 fatty acids